NuVasive® ACP System Study
At a glance
Conditions
NCT05066711
Where you'd take part
This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Atlantic Brain and Spine
Wilmington, North Carolinano site contact published
Columbia Orthopedic Group Research
Columbia, Missourino site contact published
Duly Health and Care
Naperville, Illinoisno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Kyle Malone, MS · STUDY_DIRECTOR · Globus Medical Inc
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Complications NuVasive ACP System24 months
Rate of complications (i.e., safety) attributable to use of the NuVasive ACP System
- Radiographic Success24 months
Proportion of subjects with radiographic success at: 1. Latest time point available for patients undergoing surgery to treat advanced stage tumors 2. 24 months postoperative for subjects undergoing surgery to treat instabilities, traumatic spinal fractures, failed previous fusions, or degenerative disease